NPPA has approved an annual change of 0.0055% increase in the prices of drugs under the National List of Essential Medicines
The NPPA order also mentioned a provision of penalty for the manufacturers not computing the MRP as per the new rule
NPPA noted that a change in tax rates has an impact on the fixation of maximum retail prices of various drugs and formulations